Home・Lista de Ações・Pharma Mar SA

P
Pharma Mar SA

Fechado

76.25 -0.39

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

75.8

Máximo

76.9

Indicadores-chave
By Trading Economics
Rendimento	-2.6M -993K
Vendas	6.7M 50M
P/E Médio do Setor	25.435 56.597
EPS	-0.056
Rendimento de Dividendos	1.22
Margem de lucro	-2.002
Funcionários	505
EBITDA	-2.7M 9K

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+27.15% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	1.22% 2.18%
Próximos Ganhos	29 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	41M 1.4B
Abertura anterior	76.64
Fecho anterior	76.25

Pharma Mar SA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de set. de 2026, 23:56 UTC

Correlated Moves

NiSource Inc shares are lower in after-market trading, continuing a decline from Thursday's close, alongside CMS Energy Corp's decrease amid broader market pressures.

10 de set. de 2026, 23:56 UTC

Macro News

Copper prices are lower as rising crude oil prices above $100 create negative market sentiment. Increased treasury yields also contribute to cautious outlooks for commodities.

10 de set. de 2026, 23:56 UTC

Plexus Corp shares rose in after-hours trading, rebounding sharply from an early decline. No specific news was identified to explain the movement.

10 de set. de 2026, 23:56 UTC

State Street Corp shares are trading lower in after-market hours. No specific news was identified to explain this movement.

10 de set. de 2026, 23:56 UTC

PPL Corp shares are trading slightly higher in after-market hours, reflecting a modest advance since Thursday's close amid recent trading pressure.

10 de set. de 2026, 23:56 UTC

Dollar Tree Inc. shares are higher in after-market trading, gaining slightly since Thursday's close, though remaining below the 20-day moving average.

10 de set. de 2026, 23:56 UTC

Flowers Foods Inc shares are higher in after-market trading, rebounding from an early dip. The stock remains below its 20-day moving average.

10 de set. de 2026, 23:56 UTC

UFP Technologies Inc shares are higher in after-market trading, showing notable upward movement since Thursday's close, despite recent declines and no specific news.

10 de set. de 2026, 23:56 UTC

Medtronic PLC shares are lower in after-market hours, continuing a trend from recent sessions. Volatility marked today's trading, with no specific news identified.

10 de set. de 2026, 23:52 UTC

The AUD/CHF is trading lower today, with no specific news identified. It remains near the upper end of its one-month trading range.

10 de set. de 2026, 23:51 UTC

News

The Nikkei 225 Index is lower in after-market hours, pressured by rising oil prices above $100 and a recent European Central Bank rate hike.

10 de set. de 2026, 23:51 UTC

Shares of Frontier Group Holdings Inc. are lower in after-market hours, continuing a decline over the past four sessions amid broader market trends.

10 de set. de 2026, 23:51 UTC

CVS Health shares are higher in after-market trading, rebounding from earlier losses amid mixed economic data and broader market trends.

10 de set. de 2026, 23:51 UTC

Texas Pacific Land Corp shares are lower in after-market hours, continuing a trend of three consecutive sessions finishing down and trading below the 20-day moving average.

10 de set. de 2026, 23:51 UTC

iQIYI Inc shares are higher in after-market trading, recovering from an earlier decline. The stock remains below its 20-day moving average.

10 de set. de 2026, 23:51 UTC

UiPath Inc. shares are lower in after-market trading, remaining below the 20-day moving average and near the lower end of their one-month range.

10 de set. de 2026, 23:51 UTC

Progressive Corp shares are lower in after-market hours. No specific news was identified to explain the decline.

10 de set. de 2026, 23:51 UTC

Regal Rexnord Corp shares rose in after-market trading, recovering from an initial dip. The price remains below its 20-day moving average.

10 de set. de 2026, 23:51 UTC

Michigan Consumer Sentiment Preliminary Report for September 2026 Forecasts Continued Low Confidence at 51.0 Amid Rising Inflation Concerns

10 de set. de 2026, 23:51 UTC

Canada's Housing Starts Data Release on September 16, 2026, Sparks Concerns Over Slowing Construction and Affordability Challenges.

10 de set. de 2026, 23:51 UTC

Macro News

The Euro Stoxx 50 Index is lower in after-market hours, pressured by rising crude oil prices above $100 and concerns over inflation and interest rates.

10 de set. de 2026, 23:51 UTC

Consolidated Edison shares moved higher in after-hours trading, recovering from a session low. The stock is positioned near the midpoint of its one-month trading range.

10 de set. de 2026, 23:51 UTC

Zeta Global Holdings Corp. shares are lower in after-market hours, continuing a downward trend observed since Thursday's close amid broader market conditions.

10 de set. de 2026, 23:51 UTC

Correlated Moves

WEC Energy Group shares are higher in after-market hours, influenced by a rise in Consolidated Edison and broader utility sector trends.

10 de set. de 2026, 23:51 UTC

APTIV PLC shares are lower in after-market hours, continuing a downward trend since Thursday's close. The stock remains below its 20-day moving average.

10 de set. de 2026, 23:51 UTC

The AUD/JPY is trading lower, continuing a downward trend since Wednesday. It remains near the lower end of its one-month trading range.

10 de set. de 2026, 23:51 UTC

The AUD/NZD is trading lower today, with no specific news identified for the decline. It remains below Wednesday's close after earlier fluctuations.

10 de set. de 2026, 23:46 UTC

Correlated Moves

Parker-Hannifin Corp shares are lower in after-market hours, continuing recent declines influenced by Timken Co's drop and broader industrial sector sentiment.

10 de set. de 2026, 23:46 UTC

Correlated Moves

News

Valero Energy Corp is trading higher in after-market hours following a Power Inflow alert, reflecting increased buying interest among investors.

10 de set. de 2026, 23:46 UTC

Leidos Holdings Inc shares are higher in after-market trading. No specific company news was identified to explain this price movement.

Comparação entre Pares

Variação de preço

Pharma Mar SA Previsão

Preço-alvo

By TipRanks

27.15% parte superior

Previsão para 12 meses

Média 100 EUR 27.15%

Máximo 100 EUR

Mínimo 100 EUR

Com base em 1 analistas de Wall Street que oferecem metas de preço de 12 meses para Pharma Mar SA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

1 ratings

Comprar

Manter

Vender

Com base em 1 analistas que deram avaliações de ações para Pharma Mar SA - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Pharma Mar SA

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.